This training grant in Cancer Biology is a foundation for cancer research at the University of Wisconsin-Madison. Reviewers have found the track record of its trainees to be """"""""excellent"""""""", the vast majority of whom carry out biomedical research today. Its 36 """"""""exceptional"""""""" trainers provide an """"""""outstanding"""""""" training environment. Predoctoral students accepted to be trainees by this grant receive didactic training in genetics, biochemistry, normal and tumor cell biology, normal and tumor tissue development, cancer genetics, and viral oncology. Advanced innovative courses that present the latest research are provided to the trainees in their areas of specialization. Pre- and postdoctoral trainees join clinical oncology fellows to dissect together recent findings in clinical cancer research. Predoctoral trainees master experimental cancer research under the daily guidance of one of 36 professors in the Cancer Biology program, all of whom are funded with peer-reviewed grants, supported by the NIH, DOD, and/or the ACS. The didactic training coupled with the laboratory apprenticeship provides the basis for predoctoral trainees to earn a Ph.D. in Cancer Biology. Postdoctoral trainees accepted into this training grant are already experimentally accomplished. They learn a new experimental focus in cancer research both by the guidance of their individual mentor and the didactic training essential to provide them expertise in cancer research. This training grant uses innovative forums to bring pre- and postdoctoral trainees together to master cancer research, to experience the daily demands clinical oncologists encounter in diagnosing and treating cancer, and to prepare them better to translate their research findings into clinical applications. Predoctoral candidates will now be accepted into this training grant only after they have passed their preliminary exam and shown themselves committed to cancer research. In the past ten years 97% of such students in this Cancer Biology program have earned their Ph.D.s indicating that this requirement insures future trainee's similar success. Predoctoral candidates will be judged by the Cancer Biology Advisory Committee on the basis of grades, laboratory competence, letters of recommendation including one from their graduate committee ranking them both for ability and commitment to research, and on their performance in their preliminary exam. Postdoctoral applicants will be judged by the committee similarly but will need to present a seminar on their predoctoral research. This training grant has been revised from its first application to unite our predoctoral training with our ongoing postdoctoral training across our campus. We are applying for fewer pre- and post- doctoral slots (reductions of 20% and 16% respectively) to guarantee their coordinated, intensive, and successful training in Cancer Biology.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA009135-33
Application #
7661697
Study Section
Special Emphasis Panel (ZCA1-RTRB-A (M1))
Program Officer
Damico, Mark W
Project Start
1975-07-01
Project End
2012-07-31
Budget Start
2009-08-01
Budget End
2010-07-31
Support Year
33
Fiscal Year
2009
Total Cost
$475,468
Indirect Cost
Name
University of Wisconsin Madison
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Bristol, Jillian A; Djavadian, Reza; Albright, Emily R et al. (2018) A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infection. PLoS Pathog 14:e1007179
Romero-Masters, James C; Ohashi, Makoto; Djavadian, Reza et al. (2018) An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model. PLoS Pathog 14:e1007221
Huynh, Mailee; Pak, Chorom; Markovina, Stephanie et al. (2018) Hyaluronan and proteoglycan link protein 1 (HAPLN1) activates bortezomib-resistant NF-?B activity and increases drug resistance in multiple myeloma. J Biol Chem 293:2452-2465
Guo, Feng; Wlodarchak, Nathan; Menden, Patrick et al. (2018) Purification of Target Proteins from Native Tissues: CCT Complex from Bovine Testes and PP2Ac from Porcine Brains. Methods Mol Biol 1788:73-88
Barault, Ludovic; Amatu, Alessio; Siravegna, Giulia et al. (2018) Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer. Gut 67:1995-2005
Shea, Michael P; O'Leary, Kathleen A; Fakhraldeen, Saja A et al. (2018) Antiestrogen Therapy Increases Plasticity and Cancer Stemness of Prolactin-Induced ER?+ Mammary Carcinomas. Cancer Res 78:1672-1684
Helzer, Kyle T; Ozers, Mary Szatkowski; Meyer, Mark B et al. (2018) The Phosphorylated Estrogen Receptor Cistrome Identifies a Subset of Active Enhancers Enriched for Direct ER-DNA Binding and the Transcription Factor GRHL2. Mol Cell Biol :
Jallow, Fatou; Brockman, Jennifer L; Helzer, Kyle T et al. (2018) 17?-Estradiol and ICI182,780 Differentially Regulate STAT5 Isoforms in Female Mammary Epithelium, With Distinct Outcomes. J Endocr Soc 2:293-309
Evans 3rd, Edward L; Becker, Jordan T; Fricke, Stephanie L et al. (2018) HIV-1 Vif's Capacity To Manipulate the Cell Cycle Is Species Specific. J Virol 92:
Nawandar, Dhananjay M; Ohashi, Makoto; Djavadian, Reza et al. (2017) Differentiation-Dependent LMP1 Expression Is Required for Efficient Lytic Epstein-Barr Virus Reactivation in Epithelial Cells. J Virol 91:

Showing the most recent 10 out of 333 publications